Sensei Biotherapeutics (SNSE) PT Lowered to $12 at Piper Sandler After ImmunoPhage Discontinuation
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro lowered the price target on Sensei Biotherapeutics (NASDAQ: SNSE) to $12.00 (from $25.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
